In the group of conditions known as "collagen diseases" there are often morphological changes in discrete areas of the connective tissue. For example, fibrinoid degeneration of the collagen fibers and changes in the ground substance may be seen in the subcutaneous nodules of rheumatoid arthritis and in the skin lesions of lupus erythematosus. These lesions are not well understood. The more generalized alterations in the connective tissue are even more difficult to demonstrate and remain poorly defined. Using an in vivo electrometric method, we have previously determined certain physicochemical properties of normal mammalian connective tissue which are related to its amphoteric colloidal structure (1) (2) (3) (4) (5) . Since these properties may be altered in pathological states, we have adapted this method to study some of the fundamental connective tissue changes in collagen diseases of humans.
Based upon histochemical, physicochemical and morphological studies, a unified concept of the organization of the extracellular part of normal connective tissue has been developed (6) (7) (8) (9) (10) (11) . The ground substance has been characterized physicochemically as a two-phase system containing heterogeneous (soluble and insoluble) colloids, electrolytes and water. A water-rich phase containing the soluble components is considered to be in equilibrium with a colloid-rich phase. The existence of these phases at a submicroscopic level has been demonstrated with the electron microscope. The water-rich phase consists of vacuoles with diameters ranging from 600 to 1,200 Angstrom units (7) (8) (9) (10) . These vacuoles are enclosed by a much denser colloid-rich phase. Under physiological conditions the amphoteric colloidal matrix * This work was supported in part by a grant from the Graduate Research Board, University of Illinois.
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bears a net negative charge; this is distributed between the two phases. The colloidal charge governs the distribution of mobile cations and anions through thermodynamic and electrostatic equilibrium and through the chemical binding of ions to the matrix. Electrolyte concentrations and water content in connective tissues are thus determined by the colloidal structure (1) (2) (3) (4) (5) .
Collagen, glycoproteins and mucopolysaccharides, including chondroitin sulfate and hyaluronic acid, have been conceived to be constituents of a complex coacervate in the matrix of dermal connective tissue (12) . The isoelectric point of the matrix ranges from about pH 2.2 to 2.5 depending on its composition. The low isoelectric point is a result of the acidic character of substances such as chondroitin sulfate and other mucopolysaccharides. The density of negative charge of the colloidal matrix is related to the number of titratable groups which bind hydrogen ions between pH 7.4 (physiological) and the isoelectric point (pH 2.2 to 2.5). This depends on the compostion of the matrix with respect to all the colloidal components. That these form complex insoluble aggregates may be inferred from the difficulties usually encountered in attempts to isolate the colloidal components in pure form.
When the enzyme hyaluronidase is injected into the dermis, hyaluronic acid and some of the chondroitin sulfate are disaggregated. This leads to measurable changes in spreading properties and to a lowering of the negative charge density (13) (14) (15) (16) . The effect may be explained by: 1) removal of negatively charged components, such as hyaluronic acid and chondroitin sulfate A, accompanied by 2) redistribution of water and electrolytes within the region of spreading. By the action of the enzyme, the normal balance between soluble and insoluble colloidal components is disturbed, and the remaining insoluble colloids are characterized by-2153 a low density of negative charge. In animal experiments, the effect of hyaluronidase applied subcutaneously is to lower the negative colloidal charge to less than half the initial level (14) . The initial state, as indicated by the negative charge density, may be compared with a hyaluronidasemodified state produced during a standard time interval. After the colloidal charge density becomes minimal the subsequent recovery curve, observed electrometrically, illustrates the functional state of the connective tissue (14.16). The serial electrometric evaluation of colloidal charge offers a means of comparing normal and pathological tissues and the effects of various treatments.
THEORETICAL
At an equilibrium boundary between a charged colloidal surface and an isotonic saline solution there is a difference of potential which depends on the density of colloidal charge and on the composition of the applied electrolyte solution (5, 17, 18) . This is the normal Donnan potential, ED, which is related to the Donnan ratio, r, by the formula:
2 ED' -ED = 96,500 (n,' -n2l) [2] where n,' and n2' denote the fractions of current carried respectively by cations and anions in the colloidal phase. The difference is related to the Donnan ratio, r, by the formula:
nil-n2l = r2 + 1.52 [3] where 1.52 is the ratio of the ionic conductance of chloride to that of sodium (5, 17) . [5] where Ed denotes the difference (ED'-ED), and is termed the "dilution potential." On the basis of this method, titration curves of numerous colloidal surfaces have been measured. These include dermis, cartilage and epidermis in vivo, and wool surfaces in vitro (5, 17, 18) .
MATERIAL AND METHODS
The connective tissue function test was performed in 10 healthy persons and in 14 untreated patients with various connective tissue diseases. The age and sex distributions of the two groups are given in Table I . The following pathological conditions were studied: rheumatoid arthritis (3 cases), systemic lupus erythematosus (3 cases), and scleroderma (8 cases). In addition, the alteration in connective tissue was also investigated in 3 patients with Cushing's syndrome. A number of patients in each group was retested after periods of treatment.
Displaced Donnan potentials in dermal connective tissue were measured by a modification of the method previously described for animal studies (5, (14) (15) (16) . Details of the method are as follows: a 25 gauge platinum needle with a glass hub was inserted into the dermis on the anterior surface of the right forearm.' The reference 1 In human subjects the use of a platinum needle is preferable to surgical exposure of the dermis and direct application of the solutions. In experiments with rats and rabbits the dilution potential in the dermis has been found to be about -2 mv after direct exposure of the tissue to the dilute solution (5). The same result has been found in a series of animals and humans using the platinum needle technique. In both series of experiments the calculated value of x is about 0.050 Eq. Since the platinum needle is filled with saline solution, the metal is at constant potential. Contact with the solution is made by means of saturated KCl, and there is no An initial potential (El) between the experimental (forearm dermis) and reference (finger) sites was determined with solution I (buffered isotonic NaCl) at the experimental junction. The solution was then aspirated and replaced by 0.1 to 0.2 ml of a 1/10 dilution (0.015 M metallic contact with the platinum. For these reasons the flow of current is entirely through the solutions. The system may therefore be treated by the same theoretical and mathematical methods that have been applied to wool, epidermis, and to surgically exposed tissue surfaces (5, 17, 18) . In most subjects, the magnitude of the potential E, was about 40 to 50 mv, with the experimental (forearm) junction positive with respect to the reference (finger) junction. The sign of the potential always refers to the experimental site. NaCl, solution II). The displaced potential (E2) was measured. The initial potential was then re-established with solution I at the experimental site. Each value was based on the mean of two consecutive readings taken over a period of 2 to 3 minutes. The mean value of (E2 -E,) measured before the action of hyaluronidase is denoted as the initial dilution potential, Ed'. The potentials E, and E2 were generally quite constant and reproducible. The values of E, preceding the measurement of E2 generally agreed to within 0.5 mv. Two values of E1 following the measurement of E2 agreed equally well (Table II) Equation 5 . The values of x may thus be followed in relation to time after the action of the enzyme.
TEST OF CONNECTIVE TISSUE REACTIVITY IN COLLAGEN DISEASES

RESULTS
Normal subjects. In a typical experiment on healthy young adults, the initial value of the dilu- to a value of 0.035 Eq, or to a dilution potential of -5 mv. In the control series, potentials were observed over a period of 3 to 4 hours after the minimal potentials had been observed. In every case half-recovery had occurred within that time. The average half-recovery period for 10 normal subjects was found to be 156 minutes (Table I) . On the basis of animal experiments it has been found that recovery of colloidal charge after the action of hyaluronidase follows a logarithmic equation (16) . It follows that half-recovery times may be conveniently estimated from a small number of serial measurements of dilution potential ( Figure  2 ). It is assumed that at any time t after the removal of the enzyme, the rate of recovery is proportional to the displacement of x from the initial value, x0. This is represented by the formula (15, 16) where the constant B is obtained from the maximum displacement (Edo-Ed) at zero time (beginning of recovery). In the computations it is convenient to use common rather than natural logarithms. Then log10 (Ed0 -Ed)= -kt + log10 (Edo-Ed') [9] where Ed is the dilution potential at time t, Edo is the value before use of hyaluronidase, Ed' is the value of the maximally displaced dilution potential at zero time, and k is a rate constant expressed in reciprocal minutes. The relation between k and a is: a = 2.303 k, where 2.303 is the conversion factor between common and natural logarithms. Equation 9 has been found to give an adequate description of the data in a large number of animal experiments (15, 16) . Half-recovery time and the rate constant, k, are related by the formula: t = 0.301/k, where 0.301 is the logarithm of 2, and t1 is the half-recovery time. From the data for 10 healthy subjects, values of k and t1 were calculated. This requires values of Edo, Ed' and of the serial dilution potentials Ed as a function of time after maximal enzyme effect. The mean halfrecovery time (Table I) agrees well with that estimated from the normal time-response curve shown in Figure 2 .
Connective tissue diseases. In patients with connective tissue diseases, the negative charge density, x, of the dermal colloids was about 30 to 60 per cent lower than that found in healthy subjects. The mean value was approximately 35 mEq in Rheumatoid Arthritis dx/dt = a (x0-x) [6] where a is a rate constant expressed in reciprocal minutes. By integration ln (x-x) =-at + C [7] where C is the integration constant, and ln is the natural logarithm. (Figure 6 ; Table I ). Recovery was very rapid, however, and the initial negative charge was fully restored within 2 to 3 hours, while the half-recovery time was about 60 minutes. Effects of treatment. One patient with rheumatoid arthritis was restudied after 2 weeks of treatment with sodium salicylate (600 mg four times daily). The time-response curve is compared with that of the untreated group in Figure   3 . Although the initial density of negative charge was slightly higher after therapy, the level was still considerably below the normal control level. Hyaluronidase produced only a slight change in this level, presumably due to the inhibitory effect of salicylate (19) . No recovery was noted during the 3.5-hour observation period. The patient continued to receive salicylate for another week and was then retested 36 hours after discontinuation of treatment. The results at that time closely approximated the original curve observed previous to any treatment.
One patient with systemic lupus erythematosus was given prednisone (50 mg daily) for 10 weeks before retesting. After this treatment the initial negative charge density was not significantly changed. The change after hyaluronidase remained greater than normal, but was less than in the untreated patients. The recovery curve paralleled the normal, but remained approximately 5 mEq lower throughout (Figure 4 ).
Three patients with scleroderma were restudied after 3 to 12 months of treatment with prednisone (20 to 25 mg daily) . The initial density of negative charge had increased by about 10 mEq. The change after hyaluronidase was slightly less than in the untreated cases, and some recovery was observed after the initial effect of the enzyme (Figure 5 More recently several procedures using hyaluronidase and dyes have been described (22) (23) (24) (25) . The spreading reaction appears to be very complex; it depends not only on the state of the tissue but also on the method of injection, the affinity of the tissue for the indicator, and the degree of irritation produced by the dye ( 13). Moreover the effect of recovery on the spreading reaction is difficult to delineate. For these reasons the interpretation of dye diffusion experiments may be equivocal. The colloidal state of the ground substance can be more directly studied by using the electrometric method outlined in this report. Kinetics of the response can be quantitatively followed. In this way the stages of breakdown and recovery are sharply defined.
In untreated patients a clear distinction between the various connective tissue diseases cannot be made on the basis of electrometric measurements. When the time-response curves are compared with the normal curve, however (Figures 3-5) , three characteristics of these pathological conditions may be distinguished: 1) the initial colloidal charge density is lower in the patients with rheumatoid arthritis, scleroderma and systemic lupus erythematosus; 2) the colloidal charge density after hyaluronidase becomes very low ( (27) . Clinical and histological observations on wound repair, however, also indicate a more rapid recovery rate. In the electrometric studies the recovery is influenced by the flow of colloids from contiguous areas and by cellular synthesis of new materials. Fluidity seems to be enhanced in Cushing's syndrome or by administration of cortisone (14) , and to be lowered in collagen diseases.
The results of therapy, particularly when the same drug was used, show that there are also characteristic differences between the various conditions. The time-response curve in the patient with systemic lupus erythematosus receiving prednisone approximated the normal curve fairly well, in contrast with the time-response curves of patients with scleroderma who were receiving similar treatment.
This difference in response is in accordance with clinical experience. Electrometric changes do not, however, always parallel the clinical response to therapy. In the case of rheumatoid arthritis, for example, salicylates produced remission of symptoms with relatively small changes observed in the state of the tissue colloids, -as measured by colloidal charge. It is evident that "clinically successful" treatment is not always synonymous with reversal of the pathological tissue changes.
Whereas under normal circumstances a compound such as cortisone retards repair, it promotes a remission of symptoms in many connective tissue diseases. The following explanation is suggested. Cortisone stimulates the connective tissuecells to form ground substance which differs qualitatively from the normal and which is characterized by a low density of negative colloidal charge (low cation binding). This has been demonstrated in electrometric studies on animals (14) and in the patients with Cushing's syndrome. In the normal subject the altered ground substance formed in response to cortisone interferes with proper healing. In the pathological state, however, the same modified ground substance represents a partial reversal of the disease process. In the healthy subject the modified ground substance is characterized by lowered The results indicate that in these connective tissue diseases a ground substance is formed which differs both qualitatively and quantitatively from the normal. The rate of reconstitution after enzymatic action is markedly delayed. The administration of corticosteroids tends to reverse these conditions. The measurements of changes in the state of the ground substance after the injection of hyaluronidase is a useful test for evaluating connective tissue diseases and the effects of therapy.
